American CryoStem Corporation
CRYO · OTC
9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | |
|---|---|---|---|---|
| Market Cap | $18,102 | $18,856 | $17,610 | $31,566 |
| - Cash | $8 | $42 | $24 | $68 |
| + Debt | $1,151 | $952 | $1,000 | $776 |
| Enterprise Value | $19,245 | $19,766 | $18,586 | $32,273 |
| Revenue | $21 | $558 | $322 | $1,103 |
| % Growth | -96.3% | 73.5% | -70.8% | – |
| Gross Profit | $7 | $514 | $290 | $806 |
| % Margin | 34.1% | 92.1% | 90.1% | 73.1% |
| EBITDA | -$2,165 | -$521 | -$908 | -$1,213 |
| % Margin | -10,513.2% | -93.4% | -282.4% | -110% |
| Net Income | -$2,880 | -$1,179 | -$1,082 | -$1,491 |
| % Margin | -13,985.4% | -211.4% | -336.5% | -135.1% |
| EPS Diluted | -0.05 | -0.02 | -0.02 | -0.03 |
| % Growth | -149.5% | 0% | 33.3% | – |
| Operating Cash Flow | -$304 | -$515 | -$497 | -$174 |
| Capital Expenditures | -$91 | -$13 | -$50 | -$225 |
| Free Cash Flow | -$395 | -$527 | -$547 | -$399 |